Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.ExonHit Therapeutics has received two grants of $0.3m to support two of its Research & Development projects: AclarusDx in Alzheimer's disease and the EHT 107 program in oncology, under the Qualifying Therapeutic Discovery Project Program.
Subscribe to our email newsletter
The two grants totaling were awarded to ExonHit by the US Secretary of Health and Human Services to support its Alzheimer’s disease and oncology research and development projects.
ExonHit Therapeutics executive vice president Matthew Pando said that these awards also further highlight the ability of their Genome-Wide SpliceArray discovery platform to generate both innovative diagnostic and therapeutic products.
"These grants will contribute to support the ongoing development of two programs targeting areas of high medical need," Pando said.